IP Library Granted Patent US 12,458,435
Granted Patent B2
US 12,458,435 · App. 16/255,579 · Granted Nov 4, 2025

Multielectrode catheter

Inventor: Paul J. Coates (Corte Madera, CA)
Assignee: Medtronic Ireland Manufacturing Unlimited Company
A61B18/1492A61N1/025A61N1/0529A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00875A61B18/082A61B18/1206A61B2018/1253A61B2018/126A61B2018/1435A61B2018/1467A61N1/0551
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,435
App. No.
16/255,579
Granted
Nov 4, 2025
Kind
B2
Abstract

In some examples, a catheter includes an elongated member comprising an electrode array including a distal electrode, a proximal electrode proximal to the distal electrode, and at least one intermediate electrode between the proximal and distal electrodes. The at least one intermediate electrode and at least one of the distal electrode or the proximal electrode differ in at least one electrode characteristic by at least a predetermined threshold. In some examples, delivery of a given electrical signal by each of the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode generates, for a given tissue site, substantially similar electric fields. In other examples, delivery of a given electrical signal by each of the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode generates, for a given tissue site, different electric fields.

Claims (30)

1 . A catheter comprising:

an elongated member configured to be navigated through vasculature of a patient, wherein the elongated member comprises an electrode array including:

a distal electrode;

a proximal electrode proximal to the distal electrode; and

at least one intermediate electrode between the distal electrode and the proximal electrode, wherein the electrode array is configured such that energy can be delivered to the at least one intermediate electrode independent of energy delivery to at least one of the distal electrode or the proximal electrode, and wherein the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode differ in at least one electrode characteristic by at least a predetermined threshold such that delivery of a given electrical signal by each of the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode generates, for a given tissue site, substantially similar electric fields such that the electrode array is configured to generate a substantially uniform electric field with reference to a plane orthogonal to a longitudinal axis of the elongated member or an asymmetric electric field with reference to the plane orthogonal to the longitudinal axis of the elongated member.

2 . The catheter of claim 1 , wherein the distal electrode is a distal-most electrode of the electrode array and the proximal electrode is a proximal-most electrode of the electrode array.

3 . The catheter of claim 1 , wherein the at least one physical electrode characteristic includes at least one of an electrode length measured in a direction parallel to the longitudinal axis of the elongated member, an electrode surface area, an electrode shape, an electrode thickness measured in a direction orthogonal to the longitudinal axis, an electrode orientation, an electrode composition, or an electrical conductivity.

4 . The catheter of claim 1 , wherein the at least one intermediate electrode includes at least two intermediate electrodes, and wherein the at least one electrode characteristic is substantially the same for each intermediate electrode of the at least two intermediate electrodes.

5 . The catheter of claim 4 , wherein a first electrode spacing between the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode is different from a second electrode spacing between the at least two intermediate electrodes.

6 . The catheter of claim 1 , wherein the at least one electrode characteristic is substantially the same for the distal electrode and the proximal electrode.

7 . The catheter of claim 1 , wherein the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode are configured to generate lesions having a substantially similar volume in the given tissue site.

8 . The catheter of claim 1 , further comprising a distal conductive element and a proximal conductive element, wherein the distal conductive element is distal to the distal electrode and is configured to influence a distal electric field generated by delivery of a first electrical signal via the distal electrode, wherein the proximal conductive element is proximal to the proximal electrode and is configured to influence a proximal electric field generated by delivery of a second electrical signal delivered via the proximal electrode.

9 . The catheter of claim 8 , wherein the distal conductive element and the proximal conductive element influence the electric fields generated by the distal electrode and the proximal electrode to be similar to the electric fields generated by the intermediate electrodes.

10 . The catheter of claim 1 , wherein the elongated member comprises a distal portion including the electrode array, the distal portion being configured to define a helical configuration.

11 . The catheter of claim 1 , wherein the at least one intermediate electrode consists of two intermediate electrodes.

12 . The catheter of claim 1 , wherein at least one of the distal electrode, the proximal electrode, or the at least one intermediate electrode includes a continuous ring electrode or a partial ring or segmented electrode.

13 . The catheter of claim 1 , further comprising at least a first electrical conductor and a second electrical conductor, the first electrical conductor being configured to deliver a first electrical signal from a medical device to the at least one intermediate electrode, and the second electrical conductor being configured to deliver a second electrical signal from the medical device to the at least one of the distal electrode or the proximal electrode independent of delivery of the first electrical signal to the at least one intermediate electrode.

14 . The catheter of claim 1 , further comprising a plurality of electrical conductors extending within the elongated member, each electrical conductor of the plurality of electrical conductors being configured to deliver a respective electrical signal from a medical device to a respective electrode of the electrode array.

15 . The catheter of claim 1 , wherein the elongated member defines a lumen configured to receive a guidewire.

16 . A system comprising:

a catheter comprising:

an elongated member configured to be navigated through vasculature of a patient,

wherein the elongated member comprises an electrode array including a plurality of selectively activatable electrodes, the selectively activatable electrodes including:

a distal electrode;

a proximal electrode proximal to the distal electrode; and

at least one intermediate electrode between the distal electrode and the proximal electrode, wherein the at least one intermediate electrode and at least one of the distal electrode or the proximal electrode differ in at least one physical electrode characteristic by at least a predetermined threshold such that delivery of a given electrical signal by each of the at least one intermediate electrode and the at least one of the distal electrode or the proximal electrode generates, for a given tissue site, substantially similar electric fields such that the electrode array is configured to generate a substantially uniform electric field with reference to a plane orthogonal to a longitudinal axis of the elongated member or an asymmetric electric field with reference to the plane orthogonal to the longitudinal axis of the elongated member; and

a medical device electrically coupled to the at least one intermediate electrode, the distal electrode, and the proximal electrode, wherein the medical device is configured to generate and deliver at least one electrical signal via at least one electrode of the electrode array.

17 . The system of claim 16 , wherein the electrical signal comprises a radiofrequency (RF) stimulus configured to ablate tissue at a target treatment site.

18 . The catheter of claim 1 , wherein the substantially similar electric fields do not differ in volume by more than 10%.

19 . The catheter of claim 1 , wherein the at least one electrode characteristic is at least one physical electrode characteristic.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2024
From: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 067115/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2019
From: COATES, PAUL J.
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 048359/0880 →
Continuity (3)
Provisional Application 62663537 · Apr 27, 2018
Provisional Application 62621351 · Jan 24, 2018
Related Publication 20190223949A1 · Jul 25, 2019
References Cited (131)
US 4602624A · Naples et al. · 1986 [cited by applicant]
US 4649936A · Ungar et al. · 1987 [cited by applicant]
US 4764504A · Johnson et al. · 1988 [cited by applicant]
US 4976711A · Parins et al. · 1990 [cited by applicant]
US 5300068A · Rosar et al. · 1994 [cited by applicant]
US 5358514A · Schulman et al. · 1994 [cited by applicant]
US 5423744A · Gencheff et al. · 1995 [cited by applicant]
US 5571147A · Sluijter et al. · 1996 [cited by applicant]
US 5626576A · Janssen · 1997 [cited by applicant]
US 5700282A · Zabara · 1997 [cited by applicant]
US 5707400A · Terry, Jr. et al. · 1998 [cited by applicant]
US 5749914A · Janssen · 1998 [cited by examiner]
US 5865787A · Shapland · 1999 [cited by applicant]
US 5944710A · Dev et al. · 1999 [cited by applicant]
US 5983141A · Sluijter et al. · 1999 [cited by applicant]
US 6004269A · Crowley et al. · 1999 [cited by applicant]
US 6009877A · Edwards · 2000 [cited by applicant]
US 6066134A · Eggers et al. · 2000 [cited by applicant]
US 6099524A · Lipson et al. · 2000 [cited by applicant]
US 6117101A · Diederich et al. · 2000 [cited by applicant]
US 6149620A · Baker et al. · 2000 [cited by applicant]
US 6161048A · Sluijter et al. · 2000 [cited by applicant]
US 6219577B1 · Brown, III et al. · 2001 [cited by applicant]
US 6224592B1 · Eggers et al. · 2001 [cited by applicant]
US 6246912B1 · Sluijter et al. · 2001 [cited by applicant]
US 6273886B1 · Edwards et al. · 2001 [cited by applicant]
US 6283951B1 · Flaherty et al. · 2001 [cited by applicant]
US 6292695B1 · Webster, Jr. et al. · 2001 [cited by applicant]
US 6405732B1 · Edwards et al. · 2002 [cited by applicant]
US 6506189B1 · Rittman et al. · 2003 [cited by applicant]
US 6514226B1 · Levin et al. · 2003 [cited by applicant]
US 6522926B1 · Kieval et al. · 2003 [cited by applicant]
US 6562034B2 · Edwards et al. · 2003 [cited by applicant]
US 6635054B2 · Fjield et al. · 2003 [cited by applicant]
US 6685648B2 · Flaherty et al. · 2004 [cited by applicant]
US 6736835B2 · Pellegrino et al. · 2004 [cited by applicant]
US 6845267B2 · Harrison et al. · 2005 [cited by applicant]
US 6850801B2 · Kieval et al. · 2005 [cited by applicant]
US 6885888B2 · Rezai · 2005 [cited by applicant]
US 6893436B2 · Woodard et al. · 2005 [cited by applicant]
US 7149574B2 · Yun et al. · 2006 [cited by applicant]
US 7162303B2 · Levin et al. · 2007 [cited by applicant]
US 7221979B2 · Zhou et al. · 2007 [cited by applicant]
US 7381200B2 · Katoh et al. · 2008 [cited by applicant]
US 7390894B2 · Weinshilboum et al. · 2008 [cited by applicant]
US 7617005B2 · Demarais et al. · 2009 [cited by applicant]
US 7647115B2 · Levin et al. · 2010 [cited by applicant]
US 7653438B2 · Deem et al. · 2010 [cited by applicant]
US 7717948B2 · Demarais et al. · 2010 [cited by applicant]
US 7778703B2 · Gross et al. · 2010 [cited by applicant]
US 8131372B2 · Levin et al. · 2012 [cited by applicant]
US 8140170B2 · Rezai et al. · 2012 [cited by applicant]
US 8145317B2 · Demarais et al. · 2012 [cited by applicant]
US 8150518B2 · Levin et al. · 2012 [cited by applicant]
US 8150520B2 · Demarais et al. · 2012 [cited by applicant]
US 8175711B2 · Demarais et al. · 2012 [cited by applicant]
US 8888773B2 · Chang et al. · 2014 [cited by applicant]
US 9131853B2 · Tiano · 2015 [cited by examiner]
US 10130423B1 · Viswanathan · 2018 [cited by examiner]
US 20010044645A1 · Hofstad et al. · 2001 [cited by applicant]
US 20020095198A1 · Whitebook · 2002 [cited by examiner]
US 20030060858A1 · Kieval et al. · 2003 [cited by applicant]
US 20040215235A1 · Jackson · 2004 [cited by examiner]
US 20050228460A1 · Levin et al. · 2005 [cited by applicant]
US 20060206150A1 · Demarais et al. · 2006 [cited by applicant]
US 20060271111A1 · Demarais et al. · 2006 [cited by applicant]
US 20070129720A1 · Demarais et al. · 2007 [cited by applicant]
US 20070265687A1 · Deem et al. · 2007 [cited by applicant]
US 20080033426A1 · Machell · 2008 [cited by examiner]
US 20080188846A1 · Palanker · 2008 [cited by examiner]
US 20080275445A1 · Kelly · 2008 [cited by examiner]
US 20080319513A1 · Pu et al. · 2008 [cited by applicant]
US 20090036948A1 · Levin et al. · 2009 [cited by applicant]
US 20100137860A1 · Demarais et al. · 2010 [cited by applicant]
US 20100137952A1 · Demarais et al. · 2010 [cited by applicant]
US 20100174280A1 · Grimaldi · 2010 [cited by examiner]
US 20100191112A1 · Demarais et al. · 2010 [cited by applicant]
US 20100222851A1 · Deem et al. · 2010 [cited by applicant]
US 20100222854A1 · Demarais et al. · 2010 [cited by applicant]
US 20120130289A1 · Demarais et al. · 2012 [cited by applicant]
US 20120130345A1 · Levin et al. · 2012 [cited by applicant]
US 20120172837A1 · Demarais et al. · 2012 [cited by applicant]
US 20130253622A1 · Hooven · 2013 [cited by examiner]
US 20140163546A1 · Govari · 2014 [cited by examiner]
US 20160082269A1 · Moffitt · 2016 [cited by examiner]
US 20160324573A1 · Mickelson · 2016 [cited by examiner]
US 20170065343A1 · Mickelsen · 2017 [cited by examiner]
US 20170151008A1 · Mazor · 2017 [cited by examiner]
US 20170215946A1 · Lu · 2017 [cited by examiner]
US 20170215953A1 · Long · 2017 [cited by examiner]
US 20180042672A1 · Heisel et al. · 2018 [cited by applicant]
US 20180064359A1 · Pranaitis · 2018 [cited by examiner]
US 20190125422A1 · Babkin · 2019 [cited by examiner]
US 20200179044A1 · Gross · 2020 [cited by examiner]
CN 104271063A · 2015 [cited by applicant]
CN 105939686A · 2016 [cited by applicant]
WO 2006044794A2 · 2006 [cited by applicant]
WO 2009032421A2 · 2009 [cited by applicant]
WO 2012061161A1 · 2012 [cited by applicant]
WO 2013169340A1 · 2013 [cited by applicant]
WO 2015103530A1 · 2015 [cited by applicant]
P. K. Sekhar and V. Uwizeye, Review of sensor and actuator mechanisms for bioMEMS, 2012, Woodhead Publishing Limited, pp. 53, 59 (Year: 2012). [cited by examiner]
International Preliminary Report on Patentability from counterpart International Application No. PCT/US2019/014979, Jul. 28, 2020, 11 pp. [cited by applicant]
Mark R. de Jong et al. “Renal Nerve Stimulation-Induced Blood Pressure Changes Predict Ambulatory Blood Pressure Response After Renal Denervation” Mar. 9, 2016, Hypertension 2016; 68:707-714. [cited by applicant]
Search Report of Jul. 2, 2019 in PCT Application No. PCT/US2019/014979. [cited by applicant]
Allen, E.V., Sympathectomy for essential hypertension, Circulation, 1952, 6:131-140. [cited by applicant]
Bello-Reuss, E. et al., “Effects of Acute Unilateral Renal Denervation in the Rat,” Journal of Clinical Investigation, vol. 56, Jul. 1975, pp. 208-217. [cited by applicant]
Bello-Reuss, E. et al., “Effects of Renal Sympathetic Nerve Stimulation on Proximal Water and Sodium Reabsorption,” Journal of Clinical Investigation, vol. 57, Apr. 1976, pp. 1104-1107. [cited by applicant]
Bhandari, A. and Ellias, M., “Loin Pain Hematuria Syndrome: Pain Control with RFA to the Splanchanic Plexus,” The Pain Clinc, 2000, vol. 12, No. 4, pp. 323-327. [cited by applicant]
Curtis, John J. et al., “Surgical Therapy for Persistent Hypertension After Renal Transplantation” Transplantation, 31:125-128 (1981). [cited by applicant]
Dibona, Gerald F. et al., “Neural Control of Renal Function,” Physiological Reviews, vol. 77, No. 1, Jan. 1997, The American Physiological Society 1997, pp. 75-197. [cited by applicant]
Dibona, Gerald F., “Neural Control of the Kidney—Past, Present and Future,” Nov. 4, 2002, Novartis Lecture, Hypertension 2003, 41 part 2, 2002 American Heart Association, Inc., pp. 621-624. [cited by applicant]
Janssen, Ben J.A. et al., “Effects of Complete Renal Denervation and Selective Afferent Renal Denervation on the Hypertension Induced by Intrarenal Norepinephrine Infusion in Conscious Rats”, Journal of Hypertension 198… [cited by applicant]
Katholi, Richard E., “Renal Nerves in the Pathogenesis of Hypertension in Experimental Animals and Humans,” Am J. Physiol. vol. 245, 1983, the American Physiological Society 1983, pp. F1-F14. [cited by applicant]
Krum, Henry et al., “Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: A Mulitcentre Safety and Proof-of Principle Cohort Study,” Lancet 2009; 373:1275-81. [cited by applicant]
Krum, et al., “Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension.” New England Journal of Med, Aug. 2009, 361; 9, 3 pages. [cited by applicant]
Luippold, Gerd et al., “Chronic Renal Denervation Prevents Glomerular Hyperfiltration in Diabetic Rats”, Nephrol Dial Transplant, vol. 19, No. 2, 2004, pp. 342-347. [cited by applicant]
Mahfoud et al. “Treatment strategies for resistant arterial hypertension” Dtsch Arztebl Int. 2011;108:725-731. [cited by applicant]
Osborn, et al., “Effect of Renal Nerve Stimulation on Renal Blood Flow Autoregulation and Antinatriuresis During Reductions in Renal Perfusion Pressure,” Proceedings of the Society for Experimental Biology and Medicine,… [cited by applicant]
Page, I.H. et al., “The Effect of Renal Denervation on Patients Suffering From Nephritis,” Feb. 27, 1935;443-458. [cited by applicant]
Page, I.H. et al., “The Effect of Renal Denervation on the Level of Arterial Blood Pressure and Renal Function in Essential Hypertension,” J. Clin Invest. 1934; 14:27-30. [cited by applicant]
Rocha-Singh, “Catheter-Based Sympathetic Renal Denervation,” Endovascular Today, Aug. 2009, 4 pages. [cited by applicant]
Schlaich, M.P. et al., “Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept,” Hypertension, 2009; 54:1195-1201. [cited by applicant]
Schlaich, M.P. et al., “Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension,” N Engl J Med 2009; 361(9): 932-934. [cited by applicant]
Smithwick, R.H. et al., “Splanchnicectomy for Essential Hypertension,” Journal Am Med Assn, 1953; 152:1501-1504. [cited by applicant]
Symplicity HTN-1 Investigators; Krum H, Barman N, Schlaich M, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;5… [cited by applicant]
Symplicity HTN-2 Investigators, “Renal Sympathetic Denervation in Patients with Treatment-Resistant Hypertension (The Symplicity HTN-2 Trial): A Randomised Controlled Trial”; Lancet, Dec. 4, 2010, vol. 376, pp. 1903-190… [cited by applicant]
United States Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 200… [cited by applicant]
Valente, John F. et al., “Laparoscopic Renal Denervation for Intractable ADPKD-Related Pain”, Nephrol Dial Transplant (2001) 16: 1 page. [cited by applicant]
Wagner, C.D. et al., “Very Low Frequency Oscillations in Arterial Blood Pressure After Autonomic Blockade in Conscious Dogs,” Feb. 5, 1997, Am J Physiol Regul Integr Comp Physiol 1997, vol. 272, 1997 the American Physio… [cited by applicant]
Medtronic, “Symplicity Spyral™ Multi-Electrode Renal Denervation Catheter,” Instructions for Use, Jul. 2016, Rev. 1A, 144 pages. [cited by applicant]